Ritonavir: An Extraordinary Example of Conformational Polymorphism

Pharmaceutical Research - Tập 18 Số 6 - Trang 859-866 - 2001
Bauer, John1, Spanton, Stephen1, Henry, Rodger1, Quick, John1, Dziki, Walter1, Porter, William1, Morris, John1
1Pharmaceutical Products Division, Abbott Laboratories, North Chicago

Tóm tắt

Purpose. In the summer of 1998, Norvir semi-solid capsules supplies were threatened as a result of a new much less soluble crystal form of ritonavir. This report provides characterization of the two polymorphs and the structures and hydrogen bonding network for each form. Methods. Ritonavir polymorphism was investigated using solid state spectroscopy and microscopy techniques including solid state NMR, Near Infrared Spectroscopy, powder X-ray Diffraction and Single crystal X-ray. A sensitive seed detection test was developed. Results. Ritonavir polymorphs were thoroughly characterized and the structures determined. An unusual conformation was found for form II that results in a strong hydrogen bonding network A possible mechanism for heterogeneous nucleation of form II was investigated. Conclusions. Ritonavir was found to exhibit conformational polymorphism with two unique crystal lattices having significantly different solubility properties. Although the polymorph (form II) corresponding to the “cis” conformation is a more stable packing arrangement, nucleation, even in the presence of form II seeds, is energetically unfavored except in highly supersaturated solutions. The coincidence of a highly supersaturated solution and a probable heterogeneous nucleation by a degradation product resulted in the sudden appearance of the more stable form II polymorph.

Từ khóa


Tài liệu tham khảo

citation_journal_title=J. Pharm. Sci.; citation_title=Pharmaceutical applications of polymorphism; citation_author=J. Haleblian, W. McCrone; citation_volume=58; citation_publication_date=1969; citation_pages=911-929; citation_id=CR1

citation_journal_title=J. Acc. Chem. Res.; citation_title=Disappearing polymorphs; citation_author=J. Dunitz, J. Berstein; citation_volume=28; citation_publication_date=1995; citation_pages=193-200; citation_id=CR2

citation_journal_title=Int. J. Pharm.; citation_title=Characterization of famotidine polymorphs; citation_author=M. Hassan, M. S. Salem, M. S. Sueliman, N. M. Najib; citation_volume=149; citation_publication_date=1997; citation_pages=227-232; citation_id=CR3

citation_journal_title=J. Pharm. Sci.; citation_title=Polymorphism in anhydrous theophylline—Implications on the dissolution rate of theophylline tablets; citation_author=N. V. Phadnis, R. Suryanarayanan; citation_volume=86; citation_publication_date=1997; citation_pages=1256-1263; citation_id=CR4

citation_journal_title=J. Pharm. Sci.; citation_title=Polymorphism and crystallization behavior of Abbott-79175, a second generation 5-lipoxygenase inhibitor; citation_author=R. Li, P. T. Mayer, J. Trivedi, J. Fort; citation_volume=85; citation_publication_date=1996; citation_pages=773-780; citation_id=CR5

citation_journal_title=J. Pharm. Sci.; citation_title=Sulfathiazole polymorphism studied by magic-angle spinning NMR; citation_author=D. Apperley, R. Fletton, R. Harris, R. Lancaster, S. Tavener, T. Threlfall; citation_volume=88; citation_publication_date=1999; citation_pages=1275-1280; citation_id=CR6

citation_journal_title=J. Pharm. Sci.; citation_title=Demonstration of the terms enantiotropy and monotropy in polymorphism research exemplified by flurbiprofen; citation_author=M. Kuhnert-Brandstätter; citation_volume=88; citation_publication_date=1999; citation_pages=103-108; citation_id=CR7

citation_journal_title=J. Pharm. Sci.; citation_title=Solubility behavior of lamivudine crystal forms in recrystallization solvents; citation_author=C. Spancake; citation_volume=85; citation_publication_date=1996; citation_pages=193-199; citation_id=CR8

citation_journal_title=J. Pharm. Sci.; citation_title=Crystal forms of piroxicam pivalate: Preparation and characterization of two polymorphs; citation_author=L. Carima; citation_volume=87; citation_publication_date=1998; citation_pages=333-337; citation_id=CR9

Remington's Pharmaceutical Sciences, Osol, A Mack Publishing Co, 1980 pp. 1358.

citation_journal_title=J. Med. Chem.; citation_title=A novel picomolar inhibitor of HIV type1 protease; citation_author=H. L. Sham, C. Zhao, K. D. Stewart, D. Betebenner, S. Chang, H. Park, X. Kong, W. Rosenbrook, T. Herrin, D. Madigan, S. Vasavanonda, N. Lyons, A. Molla, A. Saldivar, K. C. Marsh, E. McDonald, N. E. Wideburg, J. F. Denissen, T. Robins, D. J. Kempf, J. J. Plattner, D. W. Norbeck; citation_volume=39; citation_publication_date=1996; citation_pages=392-397; citation_id=CR11

citation_journal_title=Proc. Natl. Acad. Sci.; citation_title=ABT-538 is a potent inhibitor of Human Immunodeficiency Virus protease and has high oral bioavailability; citation_author=D. Kempf, K. C. Marsh, J. F. Denissen, E. McDonald, S. Vasavanonda, C. A. Flentge, B. E. Green, L. Fino, C. H. Park, X. P. Kong, N. E. Wideburg, A. Saldivar, L. Ruiz, W. M. Kati, H. L. Sham, T. Robins, K. D. Stewart, A. Hsu, J. J. Plattner, J. M. Leonard, D. W. Norbeck; citation_volume=92; citation_publication_date=1995; citation_pages=2484-2488; citation_id=CR12

citation_journal_title=Biochem. Biophys. Res. Commun.; citation_title=Potent inhibitors of HIV-1 protease with good oral bioavailabilities; citation_author=H. L. Sham, C. Zhao, K. C. Marsh, D. A. Betebenner, S. Q. Lin, E. Mcdonald, S. Vasavanonda, N. Wideburg, A. Saldivar, T. Robins, D. J. Kempf, J. J. Plattner, D. W. Norbeck; citation_volume=211; citation_publication_date=1995; citation_pages=159-165; citation_id=CR13

citation_journal_title=J. Pharm. Sci.; citation_title=Polymorphism and drug availability; citation_author=W. I. Higuchi, P.K. Lau, T. Higuchi, J. W. Shell; citation_volume=52; citation_publication_date=1963; citation_pages=150; citation_id=CR14

J. Berridge. Proceedings of the Fourth International Conference on Harmonization, Brussels, P.F. D'Arcy, D. W. G. Harron (eds.), Physico-Chemical Characteristics of Drug Substances, Queen's University of Belfast, 1997 p. 66.

S. R. Byrn, R. Pfeiffer, and J. Stowell. Solid-State Chemistry of Drugs, second edition, SSCI Inc., 1999 p. 148.

citation_journal_title=Pharm. Res.; citation_title=Physical characterization of pharmaceutical solids; citation_author=H. Brittain, S.J. Bogdanowich, D. E. Bugay, J. DeVincentis, G. Lewens, A. Newman; citation_volume=8; citation_publication_date=1991; citation_pages=963-973; citation_id=CR17

citation_journal_title=Z. Physikal Chem.; citation_title=Uber die vermeintliche Isomeric des roten und gelben Quecksilberoxyds und die Oberflashen spannung fester Korper; citation_author=W. Ostwald; citation_volume=34; citation_publication_date=1900; citation_pages=495-503; citation_id=CR18

citation_journal_title=Mikrochim. Acta (Wien); citation_title=On the polymorphism of pharmaceuticals and other molecular crystals I; citation_author=A. Burger, R. Ramberger; citation_volume=II; citation_publication_date=1979; citation_pages=259-271; citation_id=CR19

citation_journal_title=Mikrochim. Acta (Wien); citation_title=On the polymorphism of pharmaceuticals and other molecular crystals II; citation_author=A. Burger, R. Ramberger; citation_volume=II; citation_publication_date=1979; citation_pages=273-316; citation_id=CR20

Thông tin
Thông tin xuất bản

Pharmaceutical Research

Tập 18 Số 6

859-866

Thông tin tác giả